Ultrasound features as predictive markers of BRAFV600E mutation in thyroid cancer: a systematic review and meta-analysis

被引:0
|
作者
Liu, Rongwei [1 ,2 ]
Li, Haiyuan [1 ]
Bai, Xiumei [1 ]
Yang, Hong [1 ]
He, Yun [1 ]
机构
[1] Guangxi Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, 6 Shuangyong Rd, Nanning 530021, Peoples R China
[2] Gannan Med Univ, Affiliated Hosp 1, Dept Med Ultrasound, Ganzhou, Peoples R China
关键词
Thyroid cancer; ultrasound features; BRAFV600E; meta-analysis; BRAF MUTATION; CARCINOMA;
D O I
10.21037/gs-24-134
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: Conflicting evidence exists on the predictive value of ultrasound characteristics for BRAFV600E gene expression in thyroid cancer. This study aimed to determine the predictive value of ultrasound features for BRAFV600E gene expression status in thyroid cancer. Methods: A systematic review of studies published before December 31, 2023, was conducted in the PubMed, Web of Science, and Cochrane Library databases. Studies evaluating the ultrasonographic features for predicting BRAFV600E gene mutations in thyroid cancer were included. The relevant data were extracted, and the quality of eligible studies was independently assessed by two reviewers. Statistical analysis was performed using RevMan 5.4 and Stata 12.0 software. Results: The meta-analysis included 13 studies involving a total of 2,250 thyroid cancer patients. Ultrasound features significantly associated with BRAFV600E gene expression status in thyroid cancer (P<0.05) comprised hypoechogenicity, absence of halo, irregular borders, and vertical orientation. Contrastingly, no significant differences were observed in solid composition, irregular shape, and microcalcifications (P>0.05). Among the seven ultrasound features, the ones with superior combined sensitivity for nodules were hypoechogenicity, solid composition, absence of halo, and irregular borders, with sensitivities of 0.93 [95% confidence interval (CI): 0.87-0.96], 0.93 (95% CI: 0.86-0.97), 0.83 (95% CI: 0.72-0.91), and 0.74 (95% CI: 0.64-0.83), respectively. Finally, the areas under the summary receiver operating characteristic (SROC) curve with the highest diagnostic performance were the absence of halo and hypoechogenicity, with area under the curve (AUC) of 0.84 (95% CI: 0.80-0.87) and 0.81 (95% CI: 0.77- 0.84), respectively. Conclusions: The expression status of the BRAFV600E gene in thyroid cancer correlates with nodules exhibiting hypoechogenicity, absence of halo, irregular borders, and taller-than-wide shape. Notably, the absence of a halo and hypoechogenicity were identified as the most predictive ultrasonic features. However, due to the limited sample size, there may be bias in the meta-analysis results, and more extensive research is necessary.
引用
收藏
页码:1243 / 1253
页数:14
相关论文
共 50 条
  • [21] The effect of BRAFV600E mutation on lymph node involvement in papillary thyroid cancer
    Sahin, Samet
    Daglar, Gul
    Menekse, Ebru
    Cavdarli, Busranur
    Baglan, Tolga
    TURKISH JOURNAL OF SURGERY, 2020, 36 (03) : 249 - 255
  • [22] Association between BRAFV600E mutation and the clinicopathological features of solitary papillary thyroid microcarcinoma
    Lu, Hai-Zhen
    Qiu, Tian
    Ying, Jian-Ming
    Lyn, Ning
    ONCOLOGY LETTERS, 2017, 13 (03) : 1595 - 1600
  • [23] The Association of the BRAFV600E Mutation With Prognostic Factors and Poor Clinical Outcome in Papillary Thyroid Cancer
    Kim, Tae Hyuk
    Park, Young Joo
    Lim, Jung Ah
    Ahn, Hwa Young
    Lee, Eun Kyung
    Lee, You Jin
    Kim, Kyung Won
    Hahn, Seo Kyung
    Youn, Yeo Kyu
    Kim, Kwang Hyun
    Cho, Bo Youn
    Park, Do Joon
    CANCER, 2012, 118 (07) : 1764 - 1773
  • [24] Is the BRAFV600E mutation useful as a predictor of preoperative risk in papillary thyroid cancer?
    Nam, Jung Kwang
    Jung, Chan Kwon
    Song, Byung Joo
    Lim, Dong Jun
    Chae, Byung Joo
    Lee, Nam Seop
    Park, Woo Chan
    Kim, Jeong Soo
    Jung, Sang Seol
    Bae, Ja Seong
    AMERICAN JOURNAL OF SURGERY, 2012, 203 (04) : 436 - 441
  • [25] Papillary Thyroid Carcinoma With BRAFV600E Mutation: Sonographic Prediction
    Hwang, Jiyoung
    Shin, Jung Hee
    Han, Boo-Kyung
    Ko, Eun Young
    Kang, Seok Seon
    Kim, Jong-Won
    Chung, Jae Hoon
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2010, 194 (05) : W425 - W430
  • [26] Diagnostic Value of BRAFV600E Mutation Analysis of Thyroid Nodules According to Ultrasonographic Features and the Time of Aspiration
    Moon, Hee Jung
    Kim, Eun-Kyung
    Chung, Woong Youn
    Choi, Jong Rak
    Yoon, Jung Hyun
    Kwak, Jin Young
    ANNALS OF SURGICAL ONCOLOGY, 2011, 18 (03) : 792 - 799
  • [27] BRAFV600E mutation and expression of proangiogenic molecular markers in papillary thyroid carcinomas
    Durante, Cosimo
    Tallini, Giovanni
    Puxeddu, Efisio
    Sponziello, Marialuisa
    Moretti, Sonia
    Ligorio, Claudia
    Cavaliere, Antonio
    Rhoden, Kerry J.
    Verrienti, Antonella
    Maranghi, Marianna
    Giacomelli, Laura
    Russo, Diego
    Filetti, Sebastiano
    EUROPEAN JOURNAL OF ENDOCRINOLOGY, 2011, 165 (03) : 455 - 463
  • [28] Association of microRNA Expression and BRAFV600E Mutation with Recurrence of Thyroid Cancer
    Pamedytyte, Daina
    Simanaviciene, Vaida
    Dauksiene, Dalia
    Leipute, Enrika
    Zvirbliene, Aurelija
    Sarauskas, Valdas
    Dauksa, Albertas
    Verkauskiene, Rasa
    Zilaitiene, Birute
    BIOMOLECULES, 2020, 10 (04)
  • [29] BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
    Su-jin Kim
    Kyu Eun Lee
    Jun Pyo Myong
    Jeong-hwan Park
    Yoon Kyung Jeon
    Hye Sook Min
    So Yeon Park
    Kyeong Cheon Jung
    Do Hoon Koo
    Yeo-Kyu Youn
    World Journal of Surgery, 2012, 36 : 310 - 317
  • [30] BRAFV600E Mutation is Associated with Tumor Aggressiveness in Papillary Thyroid Cancer
    Kim, Su-jin
    Lee, Kyu Eun
    Myong, Jun Pyo
    Park, Jeong-hwan
    Jeon, Yoon Kyung
    Min, Hye Sook
    Park, So Yeon
    Jung, Kyeong Cheon
    Koo, Do Hoon
    Youn, Yeo-Kyu
    WORLD JOURNAL OF SURGERY, 2012, 36 (02) : 310 - 317